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Background: hOGG1 gene plays an important role in base excision 
repair system. It encodes a glycosylase that excises 8-hydroxyguanine 
(OH8Gua) from oxidatively-damaged nucleotides. OH8Gua is a major, 
highly mutagenic form of oxidative DNA damage induced by reactive 
free radicals present in tobacco smoke. Previous studies showed that the 
presence of homologous 326Cys hOGG1 gene variants was associated 
with both a lower hOGG1 repair activity and an increased risk of lung 
cancer (especially in heavy smokers). The aim of this study was to as-
sess the frequency of hOGG1 gene polymorphic variants in codon 326 
of exon 7 in NSCLC patients from Northern Poland and to assess the 
association between polymorphisms of hOGG1 gene and NSCLC risk. 
Methods: Study group included 162 patients (36 females and 126 
males), aged from 42 to 78 years (median 63) who underwent com-
plete pulmonary resection between 1996 and 2000. The control group 
consisted of 485 healthy subjects with no evidence of lung cancer or 
other neoplasm. hOGG1 Ser326Cys polymorphism was evaluated by 
ASA-PCR method in DNA isolated from lymphocytes. Samples were 
collected from patients before surgery and stored at -80ºC. 
Result: 326Cys carriers vs Ser/Ser variant were signiﬁcantly more 
common in the NSCLC group than in controls (41,4% vs 30,7% re-
spectively; p=0,0129). 
Conclusion: The presence of 326Cys variant is associated with an 
increased risk of lung cancer.
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Background: The XPD gene is involved in nucleotide excision repair 
of DNA by opening the DNA around the damage. It also takes part 
in the initiation of RNA transcription by RNA polymerase II. The 
Lys751Gln polymorphism of this gene is suspected to be a predisposing 
factor for NSCLC development as polymorphic variants of this gene 
have different repair efﬁciency. The aim of this study was to establish 
the frequencies of the polymorphic XPD Lys751Gln genotypes in Pol-
ish population and to assess the associated risk of NSCLC development.
Materials and Methods: The study group included 162 NSCLC pa-
tients (13 females and 149 males) who underwent curative pulmonary 
resection between the year 1996 and 2000. The control group included 
485 healthy subjects. DNA was extracted from frozen blood samples. 
XPD Lys751Gln polymorphism was evaluated by PCR-RFLP based 
methods. 
Results: The frequencies of XPD gene Lys751Gln genotypes (Lys/Lys, 
Lys/Gln, Gln/Gln) in NSCLC patients were 38.3%, 43.2% and 18.5%, 
respectively and 37.1%, 46.2% and 16.7% respectively in healthy 
controls. The proportion of Gln allele carriers vs Lys homozygotes was 
insigniﬁcantly lower in the NSCLC group than in controls (61.7% vs 
62.9%, p=0.86). 
Conclusions: These results indicate that XPD (gln751 variant) poly-
morphism does not carry increased risk of NSCLC development. 
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Objective: The mortality of lung cancer in Chinese women has 
increased signiﬁcantly in the past few decades despite the fact that 
women consumed fewer cigarettes. The most common pathological 
type of lung carcinoma in Chinese women is adenocarcinoma. Emerg-
ing evidence indicated that interaction between environmental and ge-
netic factors plays an important role. The purpose of this study was to 
investigate the expression of oncoproteins such as EGFR, VEGF, p53, 
P21and CerbB2 in resectable NSCLC. Furthermore, the relationship 
between expression of oncoproteins and gender, histological subtypes, 
and clinical outcome was analyzed. 
Methods: Immunohistochemical technique was used to detect the ex-
pressions of oncoproteins such as EGFR, VEGF, p53, P21and CerbB2 
in 261 completely resectable lung cancer patients. All the patients have 
received systematic examination to determine the clinical stage from 
2005.6 to 2005.12. The pathological type was conﬁrmed again. Immu-
nohistochemical staining was used to mark the pathological section and 
the expression of oncoproteins was deﬁned that staining cells greater 
than 10% of ﬁeld. Data regarding demographics, smoking, histology, 
family history of cancer, the symptoms in the diagnosis, clinic type, the 
diameter of lesions, stage, extent of operations and FVC, FEV1, MVV 
were obtained. SPSS 10.0 was used for statistical analysis; We analyze 
the clinical characteristics and the expression of oncoproteins of the 
subjects with descriptive statistics; X2 and independent samples test 
were tested the difference of gender, clinical feature; Logistic Regres-
sion models were used to analyze the correlations between expression 
of oncoproteins and clinical features. P<0.05 represents the difference 
is signiﬁcant.
Results: There were 136 men (51.7%) and 125 women (48.3%). 
Women were found to be more likely to have adenocarcinoma with 
peripheral type. However, squamous-carcinoma with more smok-
ing and advanced stage were predominant in men (p=0.000). The 
mean diameter of lesions was smaller in women than that in men 
(p=0.000). The mean data of FVC%, FEV1%, MVV% in women was 
better compared with that in men (p=0.000). The complete resec-
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tion was achieved less often in women than in men (p=0.004). In 
men,the expression of EGFR,VEGF,p53,P21,CerbB2 of NSCLC 
was 47.1%,36.0%, 36.8%,49.3% and 30.1% respectively. In women, 
the expression of EGFR, VEGF, p53,P21, CerbB2 of NSCLC was 
42.4%,29.6%,21.6%,26.4% and 48.8% respectively. Female gender 
signiﬁcantly increased the risk of high expression of CerbB2, RR: 
2.208, 95%CI: 1.330-3.667, p=0.002, and decreased the risk of high 
expression of P21, RR: 0.372, 95%CI: 0.159--0.870 p=0.023. The high 
expression of EGFR and VEGF may indicated the poor prognosis. The 
expression of p53 was signiﬁcantly related to smoking.
Conclusions: Women with lung cancer were more peripheral type 
and smoked less intensively but had more passive smoking. Over-rep-
resentation of adenocarcinoma and smaller lesions was observed in 
the women. Women with lung cancer had a better lung function and 
expression of CerbB2 in NSCLC related to women but expression of 
P21 has been veriﬁed associated with smoking correlated with men. 
Our study suggested the interaction between environmental and genetic 
factors is important.
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The Pim-1 is a proto-oncogene and a member of the serine/threonine 
protein kinses family. The expression of Pim-1 protein is mediated 
through activation of JAK/STATs. Pim-1 is associated with multiple 
cellular functions such as proliferation, differentiation, apoptosis and 
tumorigenesis. In specially, pim-1 is known as a important player in 
the process of malignant transformation. We therefore, investigated 
whether SNPs of Pim-1 are associated with Korean lung cancer carci-
nogenesis. 
We analyzed 4 SNP points (-1969 G/A, -766 T/C, 2760 T/A and 4115 
C/A) of Pim-1 gene by using the genomic DNA from 312 Korea lung 
cancer patients and 257 healthy controls. Genotyping was performed 
by the SNP-IT, SNapShot assay and Restriction Fragment Length Poly-
morphism (RFLP). The allele frequencies of each SNP between lung 
cancer patients and controls were estimated by the chi-square tests and 
odds rations (OR) with 95% conﬁdence interval (95% CI). We explored 
the association between SNP points and clinicopathologic parameters 
of the lung cancer patients.
-1969 locus were associated with lung cancer risk. Also, in case of 
-1969 snp point, subgroup analysis of clinicopathologic parameters in 
cancer group showed signiﬁcant association with Sex, Age, Smoking, 
Drinking, and Cell Type. In CC genotype of the -766 locus, risk of lung 
cancer was associated with old age(OR=0.483; 95% CI, 0.246-0.950). 
Also, In AT genotype of the 2760 locus, Risk of lung cancer was 
increased in none smoking(OR=1.818; 95% CI, 1.018-3.223) group 
compared with smoking group in lung cancer patients.
We conﬁrmed a relation between the Pim-1 polymorphisms and signiﬁ-
cantly increased risk in certain subgroup of lung cancer patients.
This study was supported by a Grant of the Korea Health 21 R&D proj-
ect, the Ministry of Health & Welfare, Republic of Korea (A010250)
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Background: Lung tumours often display very complex karyotypes 
(reviewed in Mitelman database). There can either be additional DNA 
sequences and extra chromosomes or deletions of sequences or even 
missing whole chromosomes in otherwise polyploidic genomes. Previ-
ous molecular karyotyping experiments have shown that in chromo-
some 2 there are frequently gained sequences in lung cancer. We have 
studied DNA copy numbers in the centromeric region of chromosome 2 
and in regions 2p16 and 2p21.
Methods: 105 lung cancers (43 AC, 35 SCC, 9 LCLC, 12 SCLC, and 
6 others) were studied for chromosome 2 count using CEP-2 (alpha 
satellite) DNA probe for ﬂuorescence in situ hybridization (FISH). 82 
of these lung tumours were studied using FISH for DNA copy number 
changes in 2p16 and/or 2p21 with one to four BAC probes. Addition-
ally, 28 of the lung tumours were microdissected and analysed by frag-
ment analysis with 15 microsatelllite markers in the 2p21-p16 region. 
Allelic imbalances were determined and compared with the copy 
number results.
Results: The average of the chromosome 2 count (CEP-2 signal) 
among the 105 lung tumours was 2.7 (range 1.7 to 5.0). CEP-2 mean 
signal count varied among the lung tumour types as follows: AC: 2.6; 
SCC: 2.8; LCLC: 3.0; SCLC: 2.4. The average DNA copy number 
among the 82 tumours studied was 2.7 also in 2p16 region, studied us-
ing three different BAC probes for FISH (n= from 28 to 69 for different 
probes). In contrast, in 2p21 the DNA sequences seemed to be gained 
with respect to the CEP-2 probe in lung tumours (n=39). The average 
copy number among all lung tumours was 4.0. The mean signal count 
at 2p21 between the lung tumour types did not differ signiﬁcantly. The 
ratio between the 2p21 locus signals and CEP2 varied from 1.4 to 1.8, 
showing a low copy number gain in 2p21 in all lung tumour types.
The frequency of allelic imbalance among informative cases was 57% 
in 2p21 and varied from 46% to 68% among different markers in 2p16. 
All lung cancer types showed some allelic imbalances in 2p.
Conclusions: Majority of lung tumours had three copies of chro-
mosome 2 in tumour cells, possibly having triploid or near triploid 
genome. In 2p21 the DNA copy number was gained with respect to the 
centromere copy number. Our results showed that the region 2p21 may 
harbour DNA sequences important to the development of lung cancer. 
The results with fragment analysis and FISH were mainly similar but 
also displayed some differences. Uniparental disomy (UPD) may cause 
some of the discrepancies. Our study also showed the importance of 
using several different techniques in quantitative molecular genomic 
studies since recognition and interpretation of low copy number gains 
are difﬁcult tasks in a complex genome such as in lung cancer.
